Showing results (371-380 of 471) with videos related to

Sort By:
Pageof 48
Journal of Neuro-Oncology|July 1, 1993
Successful treatment for a metastatic supratentorial malignant rhabdoid tumorE Bouffet, D Frappaz, D Dolbeau, et al.
European Cytokine Network|October 1, 1990
TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2M Favrot, V Combaret, J Y Blay, et al.
Cytoskeleton (Hoboken, N.J.)|July 19, 2013
Biochemical evidence that human EB1 does not bind preferentially to the microtubule seamEmily O Alberico, Daniel F Lyons, Ryan J Murphy, et al.
Cancer Research|April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factorJ Y Blay, M C Favrot, S Negrier, et al.
Cancer Treatment Reviews|June 1, 1989
Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patientsT Philip, A Mercatello, S Negrier, et al.
Cancer|March 15, 1994
Desmoplastic small round cell tumors of the abdomenD Frappaz, E Bouffet, D Dolbeau, et al.
Blood|September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trialN C Gorin, B Coiffier, M Hayat, et al.
International Journal of Cancer|June 19, 1991
Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
Proceedings (Baylor University. Medical Center)|October 29, 2019
Tandem Resonance metallic double-J ureteral stents in a single ureter for salvage management of chronic ureteral obstructionAndrew F Navetta, Trey D Durdin, Kim Thai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphomaT Philip, O Hartmann, P Biron, et al.
Pageof 48